HBI Deals+Insights / M&A/IPOs
Spanish based diagnostic labs group Atrys has sold 24.9% of its stake in regulatory compliance subsidiary Conversia to Arragio NW Segundo for €20m. The move comes after a disappointing year where the firm has seen its share price fall 39%.





